Success Metrics

Clinical Success Rate
91.4%

Based on 32 completed trials

Completion Rate
91%(32/35)
Active Trials
10(15%)
Results Posted
31%(10 trials)
Terminated
3(4%)

Phase Distribution

Ph phase_4
15
22%
Ph phase_1
5
7%
Ph early_phase_1
1
1%
Ph not_applicable
18
26%
Ph phase_2
7
10%
Ph phase_3
5
7%

Phase Distribution

6

Early Stage

7

Mid Stage

20

Late Stage

Phase Distribution51 total trials
Early Phase 1First-in-human
1(2.0%)
Phase 1Safety & dosage
5(9.8%)
Phase 2Efficacy & side effects
7(13.7%)
Phase 3Large-scale testing
5(9.8%)
Phase 4Post-market surveillance
15(29.4%)
N/ANon-phased studies
18(35.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.5%

32 of 37 finished

Non-Completion Rate

13.5%

5 ended early

Currently Active

10

trials recruiting

Total Trials

68

all time

Status Distribution
Active(14)
Completed(32)
Terminated(5)
Other(17)

Detailed Status

Completed32
unknown17
Recruiting8
Not yet recruiting4
Terminated3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
68
Active
10
Success Rate
91.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.0%)
Phase 15 (9.8%)
Phase 27 (13.7%)
Phase 35 (9.8%)
Phase 415 (29.4%)
N/A18 (35.3%)

Trials by Status

not_yet_recruiting46%
recruiting812%
completed3247%
terminated34%
unknown1725%
withdrawn23%
active_not_recruiting23%

Recent Activity

Clinical Trials (68)

Showing 20 of 68 trialsScroll for more
NCT06672978Phase 2

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

Recruiting
NCT07492771Phase 1

MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia

Not Yet Recruiting
NCT07542314Phase 4

Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting

Not Yet Recruiting
NCT01731236Early Phase 1

CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease

Active Not Recruiting
NCT07030673Not Applicable

Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection

Recruiting
NCT05726318Phase 4

Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women

Completed
NCT04970446Phase 1

Microbial Restoration in Inflammatory Bowel Diseases

Recruiting
NCT06696859

Patterns of Antibiotics Resistance

Not Yet Recruiting
NCT04847050Phase 2

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Completed
NCT06483971Not Applicable

Comparison of Oral Isotretinoin vs Ancomparison of Oral Isotretinoin vs Antibiotics on Corneal Thickness With AV

Active Not Recruiting
NCT05813184

Prenatal Antibiotics and Breast Milk / Neonatal IgA

Recruiting
NCT02784821Phase 2

Antibiotic "Dysbiosis" in Preterm Infants

Completed
NCT06377397Phase 3

Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates

Not Yet Recruiting
NCT04925531

Antibiotic Use in Facial Fracture Post Injury

Recruiting
NCT06154720

Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population

Completed
NCT03046082

Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit

Completed
NCT06084754Not Applicable

Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis

Unknown
NCT03159754Phase 4

Optimal Care of Complicated Appendicitis

Completed
NCT03970200Phase 2

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

Terminated
NCT04033029

Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
68